Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Login / Sign up
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Immix Biopharma Inc
Swot
Immix Biopharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Immix Biopharma Inc has 3 Strengths, 15 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(3)
Weakness
(15)
Opportunity
(2)
Threats
(1)
Others
(0)
Significant (over 30%) distance from 52 week high
PEG lower than Industry PEG
Stock with Low PE (PE < = 10)
MACD Crossover Below Signal Line
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
MACD crossed below signal line previous end of day
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Institutions decreased their shareholding last quarter
